Cargando…
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company
INTRODUCTION: Real‐world data are lacking regarding the relationship between prospectively collected patient‐reported outcomes (PROs), clinical outcomes and treatment in people with haemophilia (PWH). The Expanding Communications on Hemophilia A Outcomes (ECHO) registry was designed to address this...
Autores principales: | Hay, Charles R. M., Shima, Midori, Makris, Michael, Jiménez‐Yuste, Victor, Oldenburg, Johannes, Fischer, Kathelijn, Iorio, Alfonso, Skinner, Mark W., Santagostino, Elena, von Mackensen, Sylvia, Kessler, Craig M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894355/ https://www.ncbi.nlm.nih.gov/pubmed/33094894 http://dx.doi.org/10.1111/hae.14144 |
Ejemplares similares
-
Health‐related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors—Results from the HAVEN 2 study
por: Mancuso, Maria Elisa, et al.
Publicado: (2020) -
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies
por: Skinner, Mark W., et al.
Publicado: (2021) -
Health‐related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non‐interventional study (NIS)
por: Mahlangu, Johnny, et al.
Publicado: (2019) -
Switching treatments in haemophilia: is there a risk of inhibitor development?
por: Santagostino, Elena, et al.
Publicado: (2015) -
Measurement of joint health in persons with haemophilia: A systematic review of the measurement properties of haemophilia‐specific instruments
por: Gouw, Samantha C., et al.
Publicado: (2018)